Does failed chronic wet cough response to antibiotics predict bronchiectasis?

Vikas Goyal1, Keith Grimwood2, Julie Marchant1

  • 1Queensland Children's Medical Research Institute, The University of Queensland, Brisbane, Queensland, Australia Department of Respiratory Medicine, Royal Children's Hospital, Brisbane, Queensland, Australia.

Insights

Children with chronic wet cough unresponsive to antibiotics are significantly more likely to have bronchiectasis. Further investigation is recommended for persistent symptoms, as antibiotic response alone doesn't rule out this condition.

Area of Science:

  • Pediatric Pulmonology
  • Radiology
  • Infectious Diseases

Background:

  • Chronic wet cough in children can be challenging to diagnose.
  • Persistent respiratory symptoms may indicate underlying conditions like bronchiectasis.
  • Assessing the response to antibiotic treatment is a common diagnostic step.

Purpose of the Study:

  • To evaluate the association between chronic wet cough unresponsive to antibiotics and the likelihood of pediatric bronchiectasis.
  • To determine if multi-detector computerised tomography (MDCT) findings correlate with antibiotic response in children with persistent cough.

Main Methods:

  • Retrospective review of chest MDCT scans in children with chronic wet cough.
  • Analysis of clinical data, including antibiotic response and demographic factors.
  • Logistic regression used to assess associations between variables and bronchiectasis diagnosis.

Main Results:

  • Children with chronic wet cough persisting after 4 weeks of antibiotics had an 83.8% rate of bronchiectasis.
  • Only 25% of children whose cough resolved with antibiotics were diagnosed with bronchiectasis (adjusted OR 20.9).
  • Indigenous ethnicity was also independently associated with bronchiectasis (adjusted OR 5.86).

Conclusions:

  • MDCT scans are recommended for children with chronic wet cough unresponsive to 4 weeks of oral antibiotics.
  • While a positive response to antibiotics may reduce the likelihood, it does not entirely exclude bronchiectasis.
  • Early investigation is crucial for accurate diagnosis and management of pediatric bronchiectasis.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
1.1K
Chronic Obstructive Pulmonary Disease01:24

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
3.0K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
1.2K
Acute Respiratory Failure-V01:29

Acute Respiratory Failure-V

The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
768